TGFB1 and neoplasm: In melanoma and other cancers, TGF-β and associated miRNAs such as miR-183 and miR-1245 create an NK cell phenotype that can no longer effectively attack tumor cells, contributing to the immune equilibrium where NK cells are present but not fully functional.